JimC
![]()
Posts:2753
In the latest ASCO 2013 video, Drs. Mary Pinder, Nate Pennell, and Jack West discuss the results presented at ASCO 2013 of the GALAXY-1 trial of the HSP90 inhibitor ganetespib combined with Taxotere (docetaxel) as second line therapy for advanced NSCLC.
You can view the video here: http://cancergrace.org/lung/2013/06/19/galaxy-1-ganetespib-hsp90/
We welcome your questions and comments here.
JimC
Forum moderator
Forums